Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01134887 · ClinicalTrials.gov registry record · NA

Controlling Hypertension Outcomes by Improved Communication & Engagement

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT01134887: Completed NA study, sponsored by VA Office of Research and Development.

NCT01134887 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01134887, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

This randomized control study tested the feasibility of two communication enhancement interventions: one with veterans who had a stroke and demonstrated poorly controlled hypertension; the other with VA primary care providers who provided routine outpatient medical care to these veterans. This study intervened with both members of the provider-patient dyad in an attempt to improve the self-management of hypertension by improving communication during visits to the VA outpatient clinic, specifically by enabling veterans to communicate their questions and concerns about chronic disease self-management to their providers more effectively, and to help providers improve their ability to communicate more effectively with this population of veterans.

Interventions

  • OTHER Control
  • OTHER Informational Guide for Patients
  • BEHAVIORAL Video-Assisted Coaching
  • OTHER Monograph for Physicians
  • BEHAVIORAL Educational Coaching

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2009-09-01
Est. Completion 2017-01-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01134887

The ClinicalTrials.gov registry entry for NCT01134887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Control is the first listed.

NCT01134887 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01134887 about?

NCT01134887 is a clinical study titled "Controlling Hypertension Outcomes by Improved Communication & Engagement". This randomized control study tested the feasibility of two communication enhancement interventions: one with veterans who had a stroke and demonstrated poorly controlled hypertension; the other with VA primary care providers who provided routine outpatient medical care to these veterans. This study...

What is the current status of trial NCT01134887?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2009-09-01. Estimated completion is 2017-01-30.

What interventions are being tested in trial NCT01134887?

The interventions under investigation include: Control (OTHER), Informational Guide for Patients (OTHER), Video-Assisted Coaching (BEHAVIORAL), Monograph for Physicians (OTHER), Educational Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT01134887?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.